Friday - April 19, 2024

Category Archives: Financial Market

Limb Girdle Muscular Dystrophy (LGMD) Market Anticipating Remarkable Growth by 2032, Asserts DelveInsight | ML Bio Solutions, Asklepios, Sarepta, Atamyo, Edgewise, Vita Therapeutics, BridgeBio

Delveinsight Business Research LLP As per DelveInsight, the Limb Girdle Muscular Dystrophy Market is anticipated to evolve immensely in the coming years owing to the launch of emerging pipeline therapies and the high prevalence of the disorder in the 7MM. … Continue reading →

Post-Bariatric Hypoglycemia Market: Breakthrough Forecast Study Predicts Astounding Growth in the Upcoming Years | Eiger Biopharmaceuticals (Avexitide), Vogenx (Mizagliflozin)

Delveinsight Business Research LLP As per DelveInsight, the Post-Bariatric Hypoglycemia Market is anticipated to evolve immensely in the coming years owing to the increase in the patient pool and the expected entry of emerging therapies. DelveInsight’s “Post-Bariatric Hypoglycemia Market Insights, … Continue reading →

Huntington’s Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Annexon, Medesis, Novartis, Takeda, UniQure, Vaccinex

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Huntington’s Disease therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

Indoor Harvest Puts Multiple Value Drivers In The Queue From Its Ambitious 2023-24 Agenda ($INQD)

Speculative investors interested in high-risk-high-reward opportunities should keep an eye on Indoor Harvest Corp. (OTCPK: INQD). While the company currently trades on the OTC Pinks, it could quickly graduate to higher ranks if business traction grabs as planned. Targeting the … Continue reading →